Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9N9PY | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z003112 | IM / LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | Y1D03P1 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y004117 | SC / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | H4K3S | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z014869 | SC / LA |
Vaccine administration error: Patient received Measles, Mumps, and Rubella (MMR) Vaccine MMR Lot# Y00411 7 that had expired on 02/12/2026. The error was discovered on 03/03/2026, after administration. Parent/guardian will be notified. No adverse reactions observed at the time of administration. Revaccination recommended =28 days after the expired dose was given.
UNKNOWN
UNKNOWN
UNKNOWN
UNKNOWN
UNKNOWN